The manufacturer of Fulyzaq (crofelemer), Salix Pharmaceuticals, announced that it now has a patient assistance program (PAP) established for their medication. The drug was approved by the FDA earlier in late December 2012 to treat HIV-associated diarrhea. For those individuals without insurance and who qualify for the PAP, they can get their Fulyzaq prescriptions for free. For more information on the PAP or to apply, click here.
June 17, 2013